ARCHIVES

In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.

This article is from The Cancer Letter archive.

Vol. 39 No. 44 | November 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

NCI-Approved Clinical Trials

October 27, 2006

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

IOM Report Urges Providers To Address Psychological Needs Of Cancer Patients.

November 23, 2007